$ABT
AI AnalysisGenerated on May 11, 2026
AI Score
Hold$ABT
Abbott Laboratories
$ABTNYSEHealthcareMega-Cap
Abbott discovers, develops, manufactures, and sells health care products including diagnostics, medical devices, nutritionals, and branded generics.
Market Cap
$195.0B
Revenue (TTM)
$41.0B
+5.0%
Net Income (TTM)
$6.5B
+10.0%
EPS (TTM)
$3.72
P/E Ratio
28.0
Dividend Yield
1.8%
52-Week Range
$100-$128
Beta
0.72
Dimension Scores
Fundamental
74Technical
66Sentiment
70Risk / Reward
74Momentum
65Financial Health
Profitability
79strong
Growth
68moderate
Liquidity
82strong
Solvency
76strong
Efficiency
72strong
Valuation, technical analysis, investment thesis, risk assessment and more for $ABT
Free · No credit card required
Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.